117 related articles for article (PubMed ID: 8417559)
1. CSF homovanillic acid in schizotypal personality disorder.
Siever LJ; Amin F; Coccaro EF; Trestman R; Silverman J; Horvath TB; Mahon TR; Knott P; Altstiel L; Davidson M
Am J Psychiatry; 1993 Jan; 150(1):149-51. PubMed ID: 8417559
[TBL] [Abstract][Full Text] [Related]
2. Plasma homovanillic acid in schizotypal personality disorder.
Siever LJ; Amin F; Coccaro EF; Bernstein D; Kavoussi RJ; Kalus O; Horvath TB; Warne P; Davidson M; Davis KL
Am J Psychiatry; 1991 Sep; 148(9):1246-8. PubMed ID: 1883008
[TBL] [Abstract][Full Text] [Related]
3. Eye movement impairment and schizotypal psychopathology.
Siever LJ; Friedman L; Moskowitz J; Mitropoulou V; Keefe R; Roitman SL; Merhige D; Trestman R; Silverman J; Mohs R
Am J Psychiatry; 1994 Aug; 151(8):1209-15. PubMed ID: 8037257
[TBL] [Abstract][Full Text] [Related]
4. Eye tracking impairment in clinically identified patients with schizotypal personality disorder.
Siever LJ; Keefe R; Bernstein DP; Coccaro EF; Klar HM; Zemishlany Z; Peterson AE; Davidson M; Mahon T; Horvath T
Am J Psychiatry; 1990 Jun; 147(6):740-5. PubMed ID: 2343917
[TBL] [Abstract][Full Text] [Related]
5. Biologic factors in schizotypal personal disorders.
Siever LJ
Acta Psychiatr Scand Suppl; 1994; 384():45-50. PubMed ID: 7879643
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid homovanillic acid is correlated to psychotic features in neurological patients with delirium.
Ramirez-Bermudez J; Ruiz-Chow A; Perez-Neri I; Soto-Hernandez JL; Flores-Hernandez R; Nente F; Montes S; Rios C
Gen Hosp Psychiatry; 2008; 30(4):337-43. PubMed ID: 18585537
[TBL] [Abstract][Full Text] [Related]
7. Familial transmission of schizotypal and borderline personality disorders.
Baron M; Gruen R; Asnis L; Lord S
Am J Psychiatry; 1985 Aug; 142(8):927-34. PubMed ID: 4025588
[TBL] [Abstract][Full Text] [Related]
8. New perspectives on schizotypal personality disorder.
Kirrane RM; Siever LJ
Curr Psychiatry Rep; 2000 Feb; 2(1):62-6. PubMed ID: 11122934
[TBL] [Abstract][Full Text] [Related]
9. Borderline personality disorder: symptomatology and MMPI characteristics.
Resnick RJ; Schulz P; Schulz SC; Hamer RM; Friedel RO; Goldberg SC
J Clin Psychiatry; 1983 Aug; 44(8):289-92. PubMed ID: 6874649
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal progression of movement abnormalities in relation to psychotic symptoms in adolescents at high risk of schizophrenia.
Mittal VA; Neumann C; Saczawa M; Walker EF
Arch Gen Psychiatry; 2008 Feb; 65(2):165-71. PubMed ID: 18250254
[TBL] [Abstract][Full Text] [Related]
11. Schizophrenia-related and affective personality disorder traits in relatives of probands with schizophrenia and personality disorders.
Silverman JM; Siever LJ; Horvath TB; Coccaro EF; Klar H; Davidson M; Pinkham L; Apter SH; Mohs RC; Davis KL
Am J Psychiatry; 1993 Mar; 150(3):435-42. PubMed ID: 8434659
[TBL] [Abstract][Full Text] [Related]
12. A psychometric analysis of the social-interpersonal and cognitive-perceptual items for the schizotypal personality disorder.
Widiger TA; Frances A; Trull TJ
Arch Gen Psychiatry; 1987 Aug; 44(8):741-5. PubMed ID: 3632246
[TBL] [Abstract][Full Text] [Related]
13. Neurobiologic function and temperament in subjects with personality disorders.
Mitropoulou V; Trestman RL; New AS; Flory JD; Silverman JM; Siever LJ
CNS Spectr; 2003 Oct; 8(10):725-30. PubMed ID: 14712170
[TBL] [Abstract][Full Text] [Related]
14. A critical examination of empirical studies of the diagnosis of borderline disorders in adults.
Dahl AA
Psychiatr Dev; 1985; 3(1):1-29. PubMed ID: 4001119
[TBL] [Abstract][Full Text] [Related]
15. Schizotypal symptoms in patients with borderline personality disorders.
George A; Soloff PH
Am J Psychiatry; 1986 Feb; 143(2):212-5. PubMed ID: 3946657
[TBL] [Abstract][Full Text] [Related]
16. The significance of borderline and schizotypal overlap.
Plakun EM; Muller JP; Burkhardt PE
Hillside J Clin Psychiatry; 1987; 9(1):47-54. PubMed ID: 3653842
[TBL] [Abstract][Full Text] [Related]
17. Attentional functioning in schizotypal personality disorder.
Roitman SE; Cornblatt BA; Bergman A; Obuchowski M; Mitropoulou V; Keefe RS; Silverman JM; Siever LJ
Am J Psychiatry; 1997 May; 154(5):655-60. PubMed ID: 9137121
[TBL] [Abstract][Full Text] [Related]
18. The amphetamine challenge test in patients with borderline disorder.
Schulz SC; Cornelius J; Schulz PM; Soloff PH
Am J Psychiatry; 1988 Jul; 145(7):809-14. PubMed ID: 3381923
[TBL] [Abstract][Full Text] [Related]
19. Impaired smooth pursuit eye movement: vulnerability marker for schizotypal personality disorder in a normal volunteer population.
Siever LJ; Coursey RD; Alterman IS; Buchsbaum MS; Murphy DL
Am J Psychiatry; 1984 Dec; 141(12):1560-6. PubMed ID: 6507660
[TBL] [Abstract][Full Text] [Related]
20. Functional impairment in patients with schizotypal, borderline, avoidant, or obsessive-compulsive personality disorder.
Skodol AE; Gunderson JG; McGlashan TH; Dyck IR; Stout RL; Bender DS; Grilo CM; Shea MT; Zanarini MC; Morey LC; Sanislow CA; Oldham JM
Am J Psychiatry; 2002 Feb; 159(2):276-83. PubMed ID: 11823271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
